Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
Executive Leadership

Leading Our Way

Antoinette Gawin
President and Chief Executive Officer
Terumo BCT

Antoinette Gawin is President and Chief Executive Officer of Terumo Blood and Cell Technologies, a mission-driven medical device company that is focused on unlocking the potential of blood and cell-based therapies. The innovative company strives to advance healthcare, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.

Antoinette focuses on how the company will continue to evolve with healthcare’s rapid changes to meet more patients' needs globally. She believes medical device manufacturers must change and go beyond equipment to think about services, data management and new geographies where people do not yet have access to the technologies that can advance their health and lives. Antoinette is ensuring that Terumo Blood and Cell Technologies continues to focus on service and helping our customers solve problems — enabling them to better serve patients.

She has nearly 30 years of experience directing diverse global teams and transformational change. Building from a foundation in finance, operations and customer service, Antoinette has led joint ventures and acquisitions, as well as all aspects of marketing, strategic planning and commercial operations for divisions of companies in the healthcare, information technology and energy sectors.

Antoinette joined the company in 2016 and previously served as Executive Vice President, Global Commercial. She was responsible for leading the company’s global sales, services, marketing and commercial teams.

In her past leadership roles at Baxter Healthcare, she oversaw global market access and commercial excellence, strategy and commercial operations. For more than 20 years prior, Antoinette worked at GE Corporate and a number of subsidiaries, including GE Healthcare Technologies, GE Industrial and Power Systems and GE Information Services.

Antoinette is involved in many civic organizations, including American Friends of Watershed Trust Organization, a nonprofit focused on sustainable access to clean water in India. She lives with her family in Colorado, where they enjoy the outdoors and the performing arts.

Rusty Spinney
Chief Financial Officer
Terumo BCT

As Chief Financial Officer and Executive Vice President, Rusty Spinney has worldwide responsibility for all finance functions at Terumo Blood and Cell Technologies. Rusty oversees accounting, tax, treasury, finance, and planning and analysis.

Rusty also serves as a corporate liaison with Terumo Corporation, aligning budgeting, forecasting, month-end and quarter-end reporting processes, strategic plan financials and all other financial matters, including meeting requirements for Japan's equivalent of the Sarbanes-Oxley Act.

Rusty's expertise spans corporate finance, governance and policy, capital markets, international business and Sarbanes-Oxley Act implementation, as well as mergers, acquisitions and business integration.

Prior to his current role, Rusty held the position of Vice President of Finance and Corporate Controller, in which he was responsible for global financial reporting, technical accounting and financial controls across all world regions. Prior to joining Terumo Blood and Cell Technologies, he held leadership and financial management positions at Quiznos Inc. and Molson Coors, and he served as the European controller for Bass Brewing operations, based in England. He also provided business and advisory services for PricewaterhouseCoopers.

Rusty earned his bachelor's degree in business finance from Colorado State University.

Cynthia Hougum
Senior Vice President, Global Quality Transformation
Terumo BCT

Cynthia Hougum serves as Senior Vice President of Global Quality Transformation for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. She has 25 years of enterprise leadership experience serving in general management and executive leadership roles across GE’s Plastics, Healthcare Life Sciences and Xcellerex businesses. This included integrating multiple acquisitions, launching new products, leading global engineering teams, transforming plant operations and leveraging “big data” across GE’s industrial supply chain.

Her foundational experiences as a customer-facing scientist, developing products and leading quality improvement programs, coupled with leading teams in eight countries, uniquely position her to lead a holistic approach to world-class quality.

In addition to leading global quality transformation, Cynthia is taking a leadership role in building world-class, compliant infrastructure for the company’s continued growth, including our work to expand across geographies to ultimately serve more patients. Cynthia holds a PhD in physical-organic chemistry from Duke University and a bachelor’s degree in chemistry from Viterbo University. She is a certified Six Sigma Master Black Belt. Cynthia enjoys singing in a choir with her daughter, traveling with her family and practicing tai chi.

Scott Larson
Senior Vice President, Legal and General Counsel
Terumo BCT

Scott Larson has served as Senior Vice President, Legal and General Counsel for Terumo Blood and Cell Technologies since 2007. In this role, he serves as Corporate Secretary and Chief Compliance Officer for the organization and is responsible for managing the general legal, commercial compliance, intellectual property, government affairs and regulatory affairs teams. Scott is active in the life sciences industry and serves as Vice Chair of the Board of Directors of the Colorado Biosciences Association in addition to participating on the AdvaMed Legal Committee and Device and Diagnostics Compliance Group.

Prior to joining the company, Scott served as Senior Associate General Counsel for Amgen Inc., supporting the commercial law function for its nephrology business unit and its Canadian operations. He has also served as General Counsel for Gambro Healthcare Inc. and Coram Healthcare Corp. Scott began his career with Alston & Bird LLC in Atlanta.

Scott earned his doctorate in law from the Vanderbilt University School of Law and his bachelor's degree from Augustana College.

Bon Lopez
Senior Vice President, Human Resources
Terumo BCT

Bon Lopez serves as Senior Vice President, human resources for Terumo Blood and Cell Technologies, a medical device company with products, software and services that enable customers to collect and prepare blood and cells to help treat the challenging diseases and conditions of today and tomorrow.

Bon has more than 25 years of international business experience in the consumer-packaged goods, consumer healthcare and diagnostics/medical devices industries across the Americas, Europe and Asia in organizations such as Unilever, Novartis and Ortho Clinical Diagnostics. He has held multiple human resources leadership positions and is an expert in talent, organizational and leadership development.

Bon earned his bachelor’s degree in commerce at De La Salle University, Philippines. He has completed several executive education programs in human resources, business and strategy at the business schools of Stanford University, Babson College and Dartmouth College. For two decades, Bon has partnered with leaders as a certified executive coach. He enjoys traveling with his family and exploring new countries and cultures. In his spare time, he plays basketball and competitive badminton as well as mentoring young leaders across the world.

Cindy Ng
Senior Vice President, Global Commercial
Terumo BCT

Cindy Ng serves as Senior Vice President, Global Commercial for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. The innovative medical device company strives to advance patient care, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.

As a member of the leadership team, Cindy is responsible for front-line interactions with the company’s customers globally. This includes sales, services, clinical support, distributor management, and regional and local marketing to deliver high-impact customer experiences and a world-class presence at the local level.

Cindy is a hands-on sales and marketing practitioner with more than 25 years of experience in the pharmaceutical and medical device industry. Her commercial experience includes both direct and distributor sales and marketing roles with Roche, 3M and Sanofi. She transitioned to medical devices with Advanced Medical Optics (part of Abbott) and Pall Corporation. After Danaher Corp.’s acquisition of Pall Corp., she took on a new challenge to turn around its biopharmaceuticals business in China.

Colleen Riley
Senior Vice President, Innovation and Development
Terumo BCT

Colleen Riley serves as Senior Vice President of Innovation and Development for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. The innovative medical device company strives to advance patient care, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.

As a member of the company’s executive management committee, Colleen is responsible for building the company’s comprehensive and diverse product platforms that move beyond traditional medical devices and therapy manufacturing to include services, software and data management and allow the company to continue growing. She has identified opportunities and developed strategies for innovation, both organic and through outside partnerships. Colleen is focused on streamlining development pipelines and accelerating speed to market through lean, agile and rapid prototyping approaches. She leads Terumo Blood and Cell Technologies’ Global Innovation and Product Development functions, including engineering and software development, global scientific and clinical affairs, and new venture technologies.

A driven and innovative executive, Colleen is known for leading diverse end-to-end research and development organizations that deliver above market growth. Prior to joining Terumo Blood and Cell Technologies in 2019, Colleen served in a variety of senior leadership positions in Research and Development at Stryker, Novartis and Johnson & Johnson. She has played integral roles in leading teams in all stages of global product development in medical devices, pharmaceuticals and over-the-counter products. She also has progressive experience as a scientist, a practicing clinician and an educator. She has held faculty positions at Indiana University and has served on numerous boards.

Colleen attended Indiana University, where she earned her doctorate in optometry, a master’s degree in physiological optics and a bachelor’s degree in chemistry.

Monte Smith
Senior Vice President, Strategy and Market Development
Terumo BCT

Monte Smith serves as Senior Vice President, Strategy and Market Development for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. The innovative medical device company strives to advance patient care, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.

As a member of the company’s executive management committee, Monte drives the strategic planning process, optimizing the company’s portfolio by identifying growth and diversification opportunities, including collaborations, partnerships and acquisitions. His work includes creating enterprise-wide strategies and driving market-based prioritization to promote profitable growth while serving patients. Monte also leads multiple business areas, including therapeutic systems, autologous biologics, cell therapy technologies, pharmaceutical solutions and contract manufacturing.

Throughout Monte’s career in life sciences, he has been regarded as an executive with strategic vision and the ability to effectively lead teams across geographies. At Novo Nordisk, he focused on marketing the company’s biopharmaceuticals by leading multiple brands and sales teams throughout the United States.

Over the course of his time at Terumo Blood and Cell technologies, starting in 2015, he has shifted our therapeutic systems segment to focus on conditions of use. This has successfully lead to efforts to gain regulatory approval for indications such as therapeutic plasma exchange for sickle cell disease.

In addition to having his Lean Six Sigma Black Belt certification, Monte holds a master’s degree of business administration in marketing from the University of North Carolina. He and his wife live in Colorado, where they enjoy time outdoors.

Mike Wade
Senior Vice President, Global Technology
Terumo BCT

Mike Wade serves as Senior Vice President, Global Technology for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. He has overall responsibility for the global information technology function.

Mike also supports the organization's mission, vision and values through setting strategic direction to support global information systems requirements throughout the company. He provides leadership and direction for both long-term strategy and day-to-day operations, incorporating all functions and disciplines of IT, including project management, application development, operations, data security and infrastructure. He has over 25 years of IT experience in diverse industries including medical devices, financial services, banking, and oil and gas.

Prior to joining Terumo Blood and Cell Technologies, Mike held leadership and technology positions with Janus Capital Group, UMB Bank and Koch Industries, Inc., where he oversaw application and infrastructure capabilities, information security and project management. He has a bachelor's degree in management information systems from Fort Hays State University and a master's degree in business administration from Wichita State University.

Chris Williams
Senior Vice President, Global Manufacturing
Terumo BCT

Chris Williams serves as Senior Vice President, Global Manufacturing for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. Chris leads the manufacturing, supply chain, logistics and procurement teams.

He developed deep manufacturing experience through progressively responsible roles at Baxter, including rebuilding facilities and launching countless engineering and continuous improvement programs. He led Baxter’s European manufacturing operations, delivering dramatic cost, quality and customer service improvements.

Chris’s experience building lean, customer-focused manufacturing organizations enabled him then to transform the manufacturing infrastructure for Salter Labs and Santa Cruz Nutritionals before serving as vice president of manufacturing operations at PharMEDium Services. His foundation of process improvement and ability to build cultural bridges are skills he is using to enable teams to further Terumo Blood and Cell Technologies’ continued growth.

Chris holds a bachelor’s degree in industrial engineering from Mississippi State University. He is an avid tennis player and loves to travel in his free time.

​​​​​​​​​​​​​​​​​​​​​​​​​​​​

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}